Sri Sai College of Dental Surgery and Research Centre Report issue

Academic/Hospital Phase 1 Phase 3

Organization Overview

First Clinical Trial
2007
NCT00496847
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

Sri Sai Dental college of surgery, Vikarabad, RR Dist, AP, India.

Active Ingredients

Drugs in Phase 3 Trials (2)

becaplermin (regranex) (1 trial)

calcium phosphate (1 trial)

Drugs in Phase 1 Trials (1)

allogeneic adipose derived mesenchymal stem cell (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Mouth, Edentulous (Phase 1)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 3